Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

The Biopharmaceutical Manufacturing Survey

A Pharmaceutical Technology report looks at trends in biopharmaceutical manufacturing. This article contains bonus online-exclusive material.
Jul 2, 2009

A Pharmaceutical Technology report looks at trends in biopharmaceutical manufacturing. This article contains bonus online-exclusive material.

Truth and Transparency

Misleading the public about their investments—be it money or medicine—is unacceptable.
Jun 2, 2009

Misleading the public about their investments—be it money or medicine—is unacceptable.

Easing the Bottleneck

Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification technologies.
May 2, 2009

Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification technologies.

Parallel Tracks

Obama's cost-containment and science-innovation initiatives need to overlap.
Apr 2, 2009

Obama's cost-containment and science-innovation initiatives need to overlap.

Coming Down the Pike: Treating Epilepsy

Mar 2, 2009

Scientists studying epilepsy have traditionally focused on the comings and goings of ions through molecular channels in nerve cells, and many current antiseizure therapies seek to modulate that dynamic.

Whither FDA?

FDA's role should not be overlooked as it has been in years past.
Feb 2, 2009

FDA's role should not be overlooked as it has been in years past.

A New Start for New Cells

The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.
Jan 2, 2009

The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.

A Tale of Two Pharmaceutical Industries

China's quality approach to domestic versus exported products seems to be a lose-lose situation.
Dec 2, 2008

China's quality approach to domestic versus exported products seems to be a lose-lose situation.

Coming Down the Pike: Chaperones

Nov 2, 2008

Molecules called "chaperones" facilitate correct protein folding.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here